Browse Category

NYSE:TMO News 20 January 2026 - 21 January 2026

Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings

Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings

New York, January 21, 2026, 12:38 EST — During the regular session Thermo Fisher Scientific shares climbed roughly 1.6% to $628.63 by midday Wednesday, beating the wider market gains. This shift is crucial as investors brace for the company’s quarterly report next week, where management’s comments on lab demand and pharma services usually steer the stock’s near-term trajectory. This week,…
Thermo Fisher stock price rises nearly 2% as Australia starts Clario deal review; earnings next in focus

Thermo Fisher stock price rises nearly 2% as Australia starts Clario deal review; earnings next in focus

New York, January 21, 2026, 11:46 EST — Regular session Thermo Fisher Scientific Inc (NYSE: TMO) shares climbed roughly 1.9% to $630.48 Wednesday, outpacing the broader market as investors digested new regulatory developments around its planned Clario acquisition. The stock hit an intraday high of $631.25 earlier in the session. The Australian Competition and Consumer Commission (ACCC) has launched a…
Thermo Fisher stock price holds near $619 after-hours as tariff fears slam Wall Street

Thermo Fisher stock price holds near $619 after-hours as tariff fears slam Wall Street

New York, Jan 20, 2026, 19:41 EST — After-hours Shares of Thermo Fisher Scientific Inc (TMO) closed Tuesday up 26 cents at $619.01 and showed little movement after hours, following the 4 p.m. close. The stock traded between $607.37 and $620.75 during the session, with roughly 3.1 million shares changing hands. The quiet shift is still notable. As January enters…
Thermo Fisher stock slips as Australia opens Clario deal review — what investors watch next

Thermo Fisher stock slips as Australia opens Clario deal review — what investors watch next

New York, January 20, 2026, 13:21 EST — Regular session Shares of Thermo Fisher Scientific Inc (TMO) slipped on Tuesday following Australia’s competition watchdog launching a Phase 1 initial assessment of its planned acquisition of clinical-trial tech company Clario Holdings. The case, listed as MN-01075 in the regulator’s acquisitions register, had a market questionnaire issued on Jan. 19, with the…

Stock Market Today

  • CIBC Raises Exchange Income (TSE:EIF) Target Price to C$106, Signals 11% Upside
    January 21, 2026, 3:08 PM EST. CIBC increased its target price for Exchange Income Corp (TSE:EIF) from C$93 to C$106, indicating an 11.24% potential upside from the previous close. Other analysts echoed the optimism, with Ventum Financial, Raymond James, Canaccord Genuity, and TD Securities all raising their price targets and assigning buy or strong-buy ratings. Exchange Income's shares rose 2% to C$95.29 with solid trading volume, reflecting strong market interest. The company, valued at C$5.34 billion, reported Q3 earnings of C$1.46 per share, with a net margin of 4.64% and revenue near C$960 million. Analysts expect nearly four Canadian dollars in earnings per share this fiscal year, underscoring confidence in this aerospace and manufacturing focused firm.
Go toTop